MedTrace Logo

Genetics of Pulmonary Hypertension

NCT05550389 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2022-09-22

No results posted yet for this study

Summary

Despite the developments in recent years, pulmonary arterial hypertension (PAH) is still a disease with high mortality and morbidity. Although studies on genetic background have increased, the pathogenesis of PAH remains complex and unresolved. The most comprehensive data are related to bone morphogenetic protein receptor type 2 (BMPR2), and in recent years, new responsible or candidate genes have been identified, especially by new generation DNA sequencing In this study, it was aimed to determine the genetic background of patients with PAH and to investigate the genetics of secondary PAH not only HPAH.

Conditions

  • Pulmonary Hypertension

Sponsors & Collaborators

  • ADHAD

    collaborator UNKNOWN

  • Gazi University

    lead OTHER

Eligibility

Min Age
1 Month
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-02
Primary Completion
2023-01-31
Completion
2023-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05550389 on ClinicalTrials.gov